Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 0.89 |
| ▸ | RAB9A | P51151 | 2/20 | 0.89 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.75 |
| ▸ | HPGD | P15428 | 5/20 | 0.75 |
| ▸ | LMNA | P02545 | 4/20 | 0.75 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.75 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.75 |
| ▸ | PGR | P06401 | 2/20 | 0.75 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.75 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.75 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.75 |
| ▸ | AR | P10275 | 1/20 | 0.75 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.75 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.75 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.75 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.75 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.68 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.68 |
| ▸ | PDE4A | P27815 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL93206 | 1.00 | NPC1 (0.89) | NPC1RAB9ACYP3A4HPGDLMNA | |
| SCHEMBL30900821 | 1.00 | NPC1 (0.89) | NPC1RAB9ACYP3A4HPGDLMNA | |
| SCHEMBL29419872 | 1.00 | NPC1 (0.89) | NPC1RAB9ACYP3A4HPGDLMNA | |
| SCHEMBL1514997 | 0.94 | NPC1 (1.00) | NPC1RAB9ACYP3A4HPGDLMNA | |
| SCHEMBL29365072 | 0.94 | NPC1 (1.00) | NPC1RAB9ACYP3A4HPGDLMNA | |
| SCHEMBL38652 | 0.94 | NPC1 (1.00) | NPC1RAB9ACYP3A4HPGDLMNA | |
| SCHEMBL10453973 | 0.92 | NPC1 (0.96) | NPC1RAB9ACYP3A4HPGDLMNA | |
| SCHEMBL29380756 | 0.92 | NPC1 (0.96) | NPC1RAB9ACYP3A4HPGDLMNA | |
| SCHEMBL2526579 | 0.92 | NPC1 (0.96) | NPC1RAB9ACYP3A4HPGDLMNA | |
| Dioxybenzone SCHEMBL5011376 | 0.92 | HPGD (0.91) | NPC1RAB9ACYP3A4HPGDLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2023-03-23 | — | — | US | claimed |
| WO-2021158575-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | claimed |
| WO-2021158573-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | claimed |
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2023-03-23 | — | — | US | disclosed |
| WO-2021158573-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | disclosed |
| WO-2021158575-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | disclosed |
| US-8063097-B2 | Compositions and methods for regulating mammalian keratinous tissue | THE PROCTER & GAMBLE COMPANY (US) | 2011-11-22 | — | — | US | disclosed |
| EP-2076274-A2 | TOPICAL FORMULATIONS OF TELLURIUM-CONTAINING COMPOUNDS | Biomas Ltd. (IL) | 2009-07-08 | — | — | EP | disclosed |
| WO-2008032227-A2 | TOPICAL FORMULATIONS OF TELLURIUM-CONTAINING COMPOUNDS | BIOMAS, LTD. (IL) | 2008-03-20 | — | — | WO | disclosed |
| US-20080045479-A1 | Compositions and methods for regulating mammalian keratinous tissue | THE PROCTER & GAMBLE COMPANY | 2008-02-21 | — | — | US | disclosed |
| EP-1622582-A1 | COMPOSITIONS AND METHODS FOR REGULATING MAMMALIAN KERATINOUS TISSUE | THE PROCTER & GAMBLE COMPANY (US) | 2006-02-08 | — | — | EP | disclosed |
| WO-2004093841-A1 | COMPOSITIONS AND METHODS FOR REGULATING MAMMALIAN KERATINOUS TISSUE | THE PROCTER & GAMBLE COMPANY (US) | 2004-11-04 | — | — | WO | disclosed |
| US-5073371-A | Cationic surfactant, acrylic acid polymer, humectant | RICHARDSON-VICKS, INC. (US) | 1991-12-17 | — | — | US | disclosed |
| US-5073372-A | Comprising a cationic surfactant, a nonvolatile polysiloxane, a carboxy-containing polymer, a humectant and carrier; fat-free; anionic surfactant-free; acne | RICHARDSON-VICKS, INC. (US) | 1991-12-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | FABP2, FABP4, GUSB | NPC1 105/4885RAB9A 1281/4885CYP3A4 3571/4885 |
| US-20080045479-A1 | Compositions and methods for regulating mammalian keratinous tissue | KRT18, HKDC1, KRTCAP2 | NPC1 2224/4885RAB9A 2352/4885CYP3A4 4878/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.